Nemes Rush Group’s Globus Medical GMED Stock Holding History

Nemes Rush Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.5K	Sell	20 -20	-50%	-$1.58K	﹤0.01%	798
2026 Q2	$3.16K	Hold	40	–	–	﹤0.01%	726
2026 Q1	$3.45K	Buy	40 +16	+67%	+$1.44K	﹤0.01%	676
2025 Q4	$2.1K	Buy	24 +4	+20%	+$304	﹤0.01%	727
2025 Q3	$1.14K	Hold	20	–	–	﹤0.01%	627
2025 Q2	$1.18K	Hold	20	–	–	﹤0.01%	641
2025 Q1	$1.46K	Hold	20	–	–	﹤0.01%	626
2024 Q4	$1.65K	Buy	20 +15	+300%	+$1.18K	﹤0.01%	631
2024 Q3	$268	Sell	5 -15	-75%	-$1.06K	﹤0.01%	586
2024 Q2	$1.37K	Buy	20 +15	+300%	+$896	﹤0.01%	538
2024 Q1	$269	Buy	+5	New	+$269	﹤0.01%	647

Other funds holding GMED

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Antipodes Partners Royal Exchange, Australia $5.43B AUM 15.86% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Anchor Capital Advisors Boston, Massachusetts $3.21B AUM 13.78% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Nemes Rush Group's GMED Position: Q3 2026 in Review

Nemes Rush Group reduced its Globus Medical (GMED) stake by 50% in Q3 2026, selling an estimated $1.58K and leaving 20 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #798.

Nemes Rush Group first reported a position in GMED in Q1 2024 and has held it in 11 quarters since. The position peaked at $3.45K in Q1 2026. 295 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

Nemes Rush Group held 20 shares of Globus Medical worth $1.5K as of Q3 2026.
Nemes Rush Group sold 20 Globus Medical shares in Q3 2026, an estimated $1.58K.
Globus Medical made up ﹤0.01% of Nemes Rush Group's portfolio in Q3 2026, its #798 holding.
Nemes Rush Group first reported a position in Globus Medical in Q1 2024 and has held it in 11 quarters since.
Nemes Rush Group's Globus Medical position peaked at $3.45K in Q1 2026.
295 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Nemes Rush Group's 13F filing for Q3 2026, filed 4 Nov 2026.